20 Participants Needed

Amoxicillin for Pregnancy

JW
JD
Overseen ByJodie Dionne-Odom, MD MSPH
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 3 JurisdictionsThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

The study design is a prospective phase I pharmacokinetic study focused on dosing of 500 mg oral amoxicillin administration in pregnant women in the 2nd and 3rd trimester.

Will I have to stop taking my current medications?

You may need to stop taking certain medications that interact with amoxicillin, such as allopurinol, methotrexate, and warfarin. It's important to discuss your current medications with the trial team to see if any changes are needed.

Is amoxicillin safe to use during pregnancy?

Amoxicillin is commonly used during pregnancy and is generally considered safe, but studies show mixed results about its effects on the fetus. Some research suggests no significant risk of birth defects or other adverse outcomes, but findings are not entirely consistent.12345

How is the drug amoxicillin unique for use during pregnancy?

Amoxicillin is unique for use during pregnancy because it is a broad-spectrum antibiotic with low toxicity, making it commonly used in obstetrics. It is also recommended for anthrax prevention in pregnancy, and studies have evaluated its pharmacokinetics to optimize dosage strategies for pregnant women.24678

What data supports the effectiveness of the drug amoxicillin for use during pregnancy?

Amoxicillin is commonly used in pregnancy due to its low toxicity and is recommended for anthrax prevention. It is a broad-spectrum antibiotic, meaning it can treat a wide range of bacterial infections, and studies have shown it is often used during pregnancy without significant adverse effects.247910

Who Is on the Research Team?

JD

Jodie Dionne, MD

Principal Investigator

University of Alabama at Birmingham

Are You a Good Fit for This Trial?

This trial is for pregnant women in their 2nd or 3rd trimester who are under prenatal care and can speak English. They must not have taken amoxicillin recently, be allergic to it or similar antibiotics, have high creatinine levels indicating kidney issues, or be on certain drugs that don't mix well with amoxicillin.

Inclusion Criteria

Able to provide informed consent
Pregnant, engaged in prenatal care with a medical provider (at least one visit)
English speaking
See 1 more

Exclusion Criteria

My kidney function is impaired with a creatinine level of 1.2 mg/dL or higher.
I haven't taken amoxicillin in the last week.
Known hypersensitivity or intolerance of amoxicillin, penicillin, other beta lactam or cephalosporin antibiotics
See 1 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive 500 mg oral amoxicillin during the 2nd and 3rd trimester of pregnancy

1-8 hours per administration
Multiple visits for pharmacokinetic sampling

Follow-up

Participants are monitored for safety and effectiveness after treatment

4 weeks

What Are the Treatments Tested in This Trial?

Interventions

  • Amoxicillin
  • Probenecid
Trial Overview The study is testing how the body processes a dose of 500 mg oral amoxicillin when given to pregnant women. It's a phase I trial which means it's early in the testing process and focuses on understanding how the drug moves through and affects pregnant bodies.
How Is the Trial Designed?
1Treatment groups
Experimental Treatment
Group I: Amox 500 mgExperimental Treatment1 Intervention

Amoxicillin is already approved in European Union, United States, Canada for the following indications:

πŸ‡ͺπŸ‡Ί
Approved in European Union as Amoxicillin for:
πŸ‡ΊπŸ‡Έ
Approved in United States as Amoxicillin for:
πŸ‡¨πŸ‡¦
Approved in Canada as Amoxicillin for:

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Alabama at Birmingham

Lead Sponsor

Trials
1,677
Recruited
2,458,000+

Published Research Related to This Trial

Amoxicillin clearance rates are significantly higher during pregnancy compared to postpartum, indicating that pregnant women may process the drug differently, which could affect its effectiveness.
Simulations suggest that achieving adequate amoxicillin concentrations to prevent anthrax may be challenging during pregnancy and postpartum, raising concerns about its suitability for anthrax exposure prophylaxis in these populations.
Amoxicillin pharmacokinetics in pregnant women: modeling and simulations of dosage strategies.Andrew, MA., Easterling, TR., Carr, DB., et al.[2022]
A study of 4055 pregnant women in Finland found that penicillin, erythromycin, and pivmecillinam were the most commonly prescribed antibiotics, accounting for 65.4% of all antibiotic use during pregnancy.
The second trimester had the highest rates of antibiotic use and treated infections, suggesting that healthcare providers may need to consider individualized dosing and potentially shorter treatment durations for urinary tract infections to enhance safety and efficacy.
Antibiotics in pregnancy--a prospective cohort study on the policy of antibiotic prescription.HeikkilΓ€, AM.[2019]
In a study of 30 full-term pregnant women, amoxicillin levels were significantly higher in maternal serum (2.18 Β΅g/g) compared to amniotic fluid (0.67 Β΅g/g), umbilical blood (1.00 Β΅g/g), and placenta (1.00 Β΅g/g) two hours after oral administration, indicating limited penetration to fetal tissues.
To effectively treat infections in pregnant patients, especially targeting the fetus and placenta, a higher dose of amoxicillin may be necessary, and intravenous administration should be considered to ensure adequate drug levels.
Evaluation of the amoxicillin concentrations in amniotic fluid, placenta, umbilical cord blood and maternal serum two hours after oral administration.Zareba-Szczudlik, J., Romejko-Wolniewicz, E., Lewandowski, Z., et al.[2018]

Citations

Amoxicillin pharmacokinetics in pregnant women: modeling and simulations of dosage strategies. [2022]
Antibiotics in pregnancy--a prospective cohort study on the policy of antibiotic prescription. [2019]
Evaluation of the amoxicillin concentrations in amniotic fluid, placenta, umbilical cord blood and maternal serum two hours after oral administration. [2018]
4.United Arab Emiratespubmed.ncbi.nlm.nih.gov
Relationship Between Amoxicillin Use in Pregnancy and Congenital Anomalies: A Systematic Review. [2023]
Amoxicillin treatment of bacterial vaginosis during pregnancy. [2013]
A population-based study of maternal use of amoxicillin and pregnancy outcome in Denmark. [2019]
First-trimester exposure to amoxycillin/clavulanic acid: a prospective, controlled study. [2018]
Birth outcome and risk of neonatal hypoglycaemia following in utero exposure to pivmecillinam: a population-based cohort study with 414 exposed pregnancies. [2019]
A study of cefoxitin, moxalactam, and ceftazidime kinetics in pregnancy. [2019]
Maternal blood and amniotic fluid levels of moxifloxacin, levofloxacin and cefixime. [2018]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of ServiceΒ·Privacy PolicyΒ·CookiesΒ·Security